ATTN LogoMenu
4ARWRTier 6
기사 목록

ARROWHEAD PHARMACEUTICALS, INC. 4

0001242615-26-000002

View on SEC EDGAR

Adeoye Y. Olukotun sold 2,000 shares of Arrowhead Pharmaceuticals (ARWR) common stock at $86.96 per share, leaving him with 31,600 shares directly owned.

On August 18, 2026, reporting person Adeoye Y. Olukotun sold 2,000 shares of Arrowhead Pharmaceuticals, Inc. common stock at an average price of $86.96 per share for total proceeds of approximately $173,920, reducing his direct holdings to 31,600 shares, which includes previously reported shares underlying Restricted Stock Units, some of which remain subject to vesting conditions.

Filing Facts

CIK
879407
Ticker
ARWR
Form
4
Source Type
fda
Accession
0001242615-26-000002
Alert Tier
6
ARROWHEAD PHARMACEUTICALS, INC. 4 | ATTN